About treatment

Treatment targets in these patients is almost exclusively directed against the immune response and there are now several treatment alternatives available all with their advantages and disadvantages. Important for a good treatment (stated from our web survey) is:
- According to patients: Quality of life
- According to physicians: protection against long-term disability
- None of these are very well reflected in standard two year randomized clinical trials.
Treatments used in MS
Generic name | Brand name |
---|---|
Interferon beta (IFNβ) | Avonex, Betaferon, Extavia, Rebif, Plegridy |
Glatiramer acetate (GA) | Copaxone |
Natalizumab | Tysabri |
Fingolimod | Gilenya |
Alemtuzumab | Lemtrada |
Teriflunomide | Aubagio |
Dimethylfumarate | Tecfidera |
Daclizumab | Zinbryta |
Rituximab | Mabthera |
To find detailed description of mode of actions, doses and side effects, please visit the Medical Products Agency or the Swedish MS society and patient organizations.